Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly?
Author:
Affiliation:
1. Rush University; Chicago IL USA
2. Research Institute of Internal Medicine; Institute of Clinical Medicine; Oslo Norway
3. Department of Hematology; Oslo University Hospital Rikshospitalet; Oslo Norway
Funder
Baxter Healthcare Corporation
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12723/fullpdf
Reference30 articles.
1. Use of FEIBA and Amicar in the operating room- dental treatment of patient with hemophilia and high titer factor VIII inhibitors;Sharp;Spec Care Dentist,1986
2. A combined treatment with APCC (FEIBA) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A- a two centre experience;Holmstrom;Haemophilia,2012
3. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots;Carr;Blood Coag Fibrinolysis,1995
4. The role of recombinant factor FVIIa (rFVIIa) in fibrin structure in the absence of FVIII/FIX;He;J Thromb Haemost,2003
5. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference;Berntorp;Haemophilia,2006
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tranexamic Acid: An Evergreen Hemostatic Agent;Seminars in Thrombosis and Hemostasis;2024-02-09
2. Massive Clot Formation Following FEIBA and Tranexamic Acid Administration in Postcardiopulmonary Bypass Hemorrhage;Journal of Cardiothoracic and Vascular Anesthesia;2022-10
3. Prevention of Venous Thrombosis of Lower Limbs after Cesarean Section Based on Smart Medical Air Pressure Therapy Instrument;BioMed Research International;2022-07-30
4. Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China;Haemophilia;2022-05
5. Low dose prophylaxis and antifibrinolytics: Options to consider with proven benefits for persons with haemophilia;Haemophilia;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3